General Information of Drug Off-Target (DOT) (ID: OTNEL2PZ)

DOT Name Torsin-1B (TOR1B)
Synonyms Torsin ATPase-1B; EC 3.6.4.-; Torsin family 1 member B
Gene Name TOR1B
Related Disease
Influenza ( )
Leprosy ( )
Segmental dystonia ( )
Dystonia ( )
Tuberculosis ( )
UniProt ID
TOR1B_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.6.4.-
Pfam ID
PF21376 ; PF06309
Sequence
MLRAGWLRGAAALALLLAARVVAAFEPITVGLAIGAASAITGYLSYNDIYCRFAECCREE
RPLNASALKLDLEEKLFGQHLATEVIFKALTGFRNNKNPKKPLTLSLHGWAGTGKNFVSQ
IVAENLHPKGLKSNFVHLFVSTLHFPHEQKIKLYQDQLQKWIRGNVSACANSVFIFDEMD
KLHPGIIDAIKPFLDYYEQVDGVSYRKAIFIFLSNAGGDLITKTALDFWRAGRKREDIQL
KDLEPVLSVGVFNNKHSGLWHSGLIDKNLIDYFIPFLPLEYRHVKMCVRAEMRARGSAID
EDIVTRVAEEMTFFPRDEKIYSDKGCKTVQSRLDFH
Function
May serve as a molecular chaperone assisting in the proper folding of secreted and/or membrane proteins. Plays a role in non-neural cells nuclear envelope and endoplasmic reticulum integrity. May have a redundant function with TOR1A in non-neural tissues.
Tissue Specificity Widely expressed with low levels in brain.
Reactome Pathway
Cargo recognition for clathrin-mediated endocytosis (R-HSA-8856825 )

Molecular Interaction Atlas (MIA) of This DOT

5 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Influenza DIS3PNU3 Strong Biomarker [1]
Leprosy DISAA4UI Strong Biomarker [2]
Segmental dystonia DISOACMU Strong Genetic Variation [3]
Dystonia DISJLFGW moderate Biomarker [4]
Tuberculosis DIS2YIMD Limited Genetic Variation [5]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Torsin-1B (TOR1B). [6]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Torsin-1B (TOR1B). [7]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Torsin-1B (TOR1B). [8]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Torsin-1B (TOR1B). [9]
Marinol DM70IK5 Approved Marinol decreases the expression of Torsin-1B (TOR1B). [10]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Torsin-1B (TOR1B). [11]
Tamibarotene DM3G74J Phase 3 Tamibarotene increases the expression of Torsin-1B (TOR1B). [7]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of Torsin-1B (TOR1B). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Torsin-1B (TOR1B). [13]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Torsin-1B (TOR1B). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.PLoS One. 2013;8(1):e52198. doi: 10.1371/journal.pone.0052198. Epub 2013 Jan 9.
2 Leprosy in a high-prevalence Egyptian village: epidemiology and risk factors.Int J Dermatol. 2002 Oct;41(10):681-6. doi: 10.1046/j.1365-4362.2002.01602.x.
3 Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia.Mov Disord. 2010 Oct 15;25(13):2183-7. doi: 10.1002/mds.23225.
4 Strong genetic evidence for association of TOR1A/TOR1B with idiopathic dystonia.Neurology. 2006 Nov 28;67(10):1857-9. doi: 10.1212/01.wnl.0000244423.63406.17.
5 HLA antigen profile in pulmonary tuberculosis patients & their spouses.Indian J Med Res. 1998 Apr;107:155-8.
6 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
7 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
8 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
9 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
10 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
11 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
12 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
13 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
14 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.